Cellectar Biosciences‘ Phospholipid Drug Conjugate (PDC) research program has generated numerous PDC molecules that show “significant” improved pharmacologic activity, the company announced today. According to a release, Cellectar’s research demonstrates that…
Cellectar Biosciences’ CLR 131 has achieved an overall survival of greater than 22 months in advanced multiple myeloma patients, the company announced today. “We continue to make meaningful progress on…
SHINE Medical Technologies broke ground today on Building One, its nuclear technology facility in Janesville, Wis. The 11,500-square-foot facility, located east of Southern Wisconsin Regional Airport, will house a prototype to…
In its clinical trial to treat prostate cancer, Madison Vaccines Incorporated (MVI) announced today it has begun dosing 20 patients. According to a release, MVI is exploring the use of its gene…
Cellectar Biosciences announced today that it will collaborate with Avicenna Oncology, a clinical stage biotechnology company based in Switzerland, to develop new phospholipid drug conjugates for solid tumors. According to…
Invenra will collaborate with Merck, a pharmaceutical company, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck, the company announced recently. “We are excited to…
Exact Sciences recently announced its second quarter numbers, which included revenue of $57.6 million and 135,000 completed Cologuard tests, an increase of 172 percent and 149 percent, respectively. “As patient and…
The Wisconsin Economic Development Corporation has certified Varigen Biosciences as a Qualified New Business Venture (QNBV), the organization announced recently. According to a release, QNBV allows investors in Varigen Biosciences to receive…
Microscopy Innovations was awarded a $150,000 Phase I Small Business Technology Transfer (STTR) contract by the U.S. Army Medical Research and Material Command, the company announced today. According to a release,…
To help raise awareness of colon cancer and the importance of regular screening, professional golfer Jerry Kelly will wear a Cologuard-branded hat for the next two years, Exact Sciences announced…
